Dermatology, MOHS-Micrographic Surgery · Rochester Hills, MI
NPI
1457305815
Since 2006
Specialty
Dermatology, MOHS-Micrographic Surgery
Code 207ND0101X
Group practices
6
Medicare group memberships
Hospitals
4
Hospital affiliations
110 South Blvd W Ste 100
Rochester Hills, MI, 48307
Phone (248) 852-1900
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.1M
5,984 services
Medicare patients, 2024
1,462
Average age 76
Drug cost, 2024
$232K
5,816 prescriptions
Company payments, 2025
$609
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ayad E Abrou was code 17003 (destruction skin lesion), 986 times for 131 patients. In total Ayad E Abrou billed 5,984 services in 76 codes, and Medicare paid $1.1M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-07-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 986 | 131 | $5.17 | $5,095 |
| 17311 Mohs Surgery | Office | 933 | 805 | $508.41 | $474K |
| 99213 Office E&M - Established | Office | 883 | 625 | $66.47 | $59K |
| 17312 Mohs Surgery | Office | 450 | 309 | $331.46 | $149K |
| 13132 Wound Repair - All Levels | Office | 375 | 354 | $191.68 | $72K |
| 99212 Office E&M - Established | Office | 278 | 242 | $44.14 | $12K |
| 17000 Destruction Skin Lesion | Office | 241 | 173 | $41.61 | $10K |
| 99203 Office E&M - New | Office | 238 | 238 | $80.94 | $19K |
| 11102 Skin Biopsy | Office | 198 | 176 | $71.32 | $14K |
| 99214 Office E&M - Established | Office | 182 | 145 | $96.03 | $17K |
| 12032 Wound Repair - All Levels | Office | 135 | 129 | $173.46 | $23K |
| 17110 Destruction Skin Lesion | Office | 123 | 98 | $88.53 | $11K |
| 11103 Skin Biopsy | Office | 99 | 63 | $40.12 | $3,972 |
| 17313 Mohs Surgery | Office | 85 | 80 | $497.20 | $42K |
| 13151 Wound Repair - All Levels | Office | 84 | 84 | $169.64 | $14K |
By year: 2022 $1.0M for 6,196 services; 2023 $1.1M for 6,003 services; 2024 $1.1M for 5,984 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ayad E Abrou prescribed most often to Medicare patients was Mupirocin, with 2,300 prescriptions and refills. In total Ayad E Abrou wrote 5,816 Medicare prescriptions that cost $232K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mupirocin Generic | 2,300 | 2,311 | 1,824 | $15K |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 318 | 347 | 140 | $5,083 |
| Cephalexin Generic | 314 | 314 | 278 | $2,244 |
| Triamcinolone Acetonide Generic | 309 | 347 | 174 | $3,098 |
| Ciclopirox Generic | 275 | 311 | 107 | $8,043 |
| Metronidazole Generic | 234 | 250 | 119 | $11K |
| Acetaminophen-Codeine Acetaminophen With Codeine | 233 | 233 | 220 | $650 |
| Ketoconazole Generic | 193 | 195 | 72 | $3,854 |
| Fluocinonide Generic | 185 | 194 | 78 | $4,960 |
| Clobetasol Propionate Generic | 182 | 190 | 75 | $10K |
| Ciclopirox Ciclopirox Olamine | 144 | 157 | 81 | $3,391 |
| Clindamycin Phosphate Generic | 124 | 130 | 49 | $4,199 |
| Minocycline Hcl Generic | 113 | 119 | 40 | $1,712 |
| Hydroxyzine Hcl Generic | 108 | 137 | 52 | $1,284 |
| Hydrocortisone Generic | 94 | 95 | 53 | $678 |
Brand drugs: 173 claims; generic drugs: 5,643 claims; opioid claims: 237.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ayad E Abrou $609 ($609 in general payments such as food, travel and fees) from 14 companies. The largest payer was Novo Nordisk Inc with $82.56.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 1 | $82.56 |
| Abbvie Inc. ABBV | 3 | $68.67 |
| Genzyme Corporation SNY | 3 | $64.15 |
| Galderma Laboratories, L.P. GALD.SW | 3 | $58.64 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $53.11 |
| Organon LLC OGN | 2 | $46.76 |
| UCB, Inc. UCB.BR | 2 | $42.11 |
| Pfizer Inc. PFE | 2 | $37.1 |
| Lilly USA, LLC LLY | 2 | $36.74 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $34.39 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.